Archive: March 2024

Management of KRAS-Mutated Non–Small Cell Lung Cancer

Abstract: Kirsten rat sarcoma virus (KRAS) is the most frequently mutated oncogene in human cancers, particularly in non–small cell lung cancer (NSCLC), where mutations are present […]

Recombinant Interferon Alfa in BCR/ABL-Negative Chronic Myeloproliferative Neoplasms

Abstract: The treatment landscape for BCR/ABL-negative myeloproliferative neoplasms (MPNs), driven by JAK2, CALR, and MPL mutations, has evolved significantly over the last decade. Recent regulatory approvals […]

Epcoritamab, a Promising Therapy for Richter Syndrome?

H&O  What defines Richter syndrome? AK  Richter syndrome (RS), also known as Richter transformation, refers to the development of an aggressive lymphoma in the setting of […]

Back to Archive